-
Featured Authors
-
Archives
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: biotechnology
Shoppers Already Have a Choice Regarding Biotech Foods
Food Chemical News (an Agra Informa publication) ran a thorough editorial in its February 17 edition on the biotech food labeling debate. In this piece, Gregory Conko, a senior fellow at the Competitive Enterprise Institute, explains why it would be unnecessary to require special labeling for foods containing biotech ingredients: “Today, there are many thousands of affirmatively labeled, non-biotech foods available in stores as varied as Whole Foods Markets and Wal-Mart. “From just 2000 to Read More >
Brazilian Innovation: A Patent Success
The story of Acheflan highlights the role of patents in homegrown innovation in developing countries. Professor Michael Ryan of George Washington University Law School reviewed several case studies (including Acheflan) in Brazil that highlight the differences in biomedical innovation both pre- and post-intellectual property reforms. In the early 1980’s, Ache Laboratorios Farmaceuticos (a Brazilian generics manufacturer) became aware of a plant that grew near coastal cities that local fishermen would mash into an oil rub Read More >
BIO Applauds U.S.-Japan Action on GE Papaya
The U.S. Department of Agriculture has announced that the Government of Japan approved Hawaii’s Rainbow papaya for commercial shipment to Japan. The Rainbow papaya is genetically engineered to be resistant to the papaya ringspot virus. This announcement marks the beginning of a new chapter for Hawaiian papaya growers. “The market opening in Japan is great news for Hawaii’s papaya producers and even better news for American agricultural exports,” said Michael Scuse, Acting Under Secretary for Read More >
Georgia Bio Recognizes Two State Legislators with Annual Award
While the economic climate has been difficult for bioscience companies, it has also had a significant impact on state budgets, causing many states to cut programs and reassess economic priorities. That said, the bioscience industry has remained a valuable growth area, both in the United States and abroad. Therefore, it’s not surprising that local and state government leaders continue to support economic development initiatives that encourage the growth of this industry. This week, Georgia Bio Read More >
Illinois Sees Biotech as Key to Job Growth
For every job created in the biotech industry, up to five additional jobs are created to build research facilities; maintain laboratory and computer equipment; supply laboratory and office equipment, and provide basic services to even the most modest biotechnology facilities. David Miller of the Illinois Biotechnology Industry Organization is well aware of the above statistic. He shared his views on the challenges and payoffs tied to establishing Chicago as a high-tech employment hub earlier this Read More >
